These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1673586)

  • 1. Interrupting the adaptive changes in congestive heart failure.
    Kupper W
    Am J Cardiol; 1991 May; 67(12):20C-22C. PubMed ID: 1673586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure.
    Francis GS
    Am Heart J; 1989 Sep; 118(3):642-8. PubMed ID: 2570521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta, partial agonists to treat heart failure: effects of xamoterol upon cardiac function and clinical status.
    Heng MK
    Clin Cardiol; 1990 Mar; 13(3):171-6. PubMed ID: 1969783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac adrenoceptors in the failing heart: effect of intervention.
    Fowler MB
    Eur Heart J; 1990 Apr; 11 Suppl A():13-8. PubMed ID: 1971585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
    Richaud M; Lechat P; Komajda M; Landault C; Fournier P; Fraysse JB; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1990 Feb; 83(2):247-52. PubMed ID: 1968739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
    Ruffolo RR; Kopia GA
    Am J Med; 1986 Feb; 80(2B):67-72. PubMed ID: 2868661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac beta-adrenoceptor regulation and the effects of partial agonism.
    Barnett DB; Lu XY
    Am J Cardiol; 1991 May; 67(12):18C-19C. PubMed ID: 1673585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
    Virk SJ; Davies MK
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience of therapy with xamoterol in patients with severe systolic and diastolic dysfunction.
    Pouleur H; Hanet C; Rousseau MF
    Eur Heart J; 1990 Apr; 11 Suppl A():33-8. PubMed ID: 1971587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: effect of ACE inhibitors and other vasodilators].
    Langes K; Bleifeld W
    Herz; 1990 Jun; 15(3):164-70. PubMed ID: 2198217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of beta 1-partial agonist(ICI 118-587) on plasma catecholamines level and hemodynamics during exercise in congestive heart failure].
    Sato H; Matsuyama T; Ozaki H; Fukushima M; Matsumoto M
    Kokyu To Junkan; 1984 Nov; 32(11):1159-62. PubMed ID: 6151727
    [No Abstract]   [Full Text] [Related]  

  • 13. [Beta-adrenergic blockers in congestive heart failure: pro et contra?].
    Trifunović SL; Pavlović K
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():44-50. PubMed ID: 18193810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of the responses of the renin-angiotensin system and sympathetic nervous system to a vasodilator stimulus in congestive heart failure.
    Levine TB; Olivari MT; Cohn JN
    Int J Cardiol; 1986 Aug; 12(2):165-73. PubMed ID: 3744598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacology of xamoterol: a basis for modulation of the autonomic control of the heart.
    Snow HM
    Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):3S-13S. PubMed ID: 2572252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects.
    Lemoine H; Bilski A; Kaumann AJ
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):105-17. PubMed ID: 2468921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine activation in congestive heart failure.
    Forfar JC
    Am J Cardiol; 1991 May; 67(12):3C-5C. PubMed ID: 2021117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE; Cavero I; Manoury P; Lefevre-Borg F; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
    Maack C; Böhm M; Vlaskin L; Dabew E; Lorenz K; Schäfers HJ; Lohse MJ; Engelhardt S
    Circulation; 2003 Jul; 108(3):348-53. PubMed ID: 12847069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.